APEX disease gene resequencing: mutations in exon 7 of the p53 tumor suppressor gene.
Detection of mutations in disease genes will be a significant application of genomic research. Methods for detecting mutations at the single nucleotide level are required in highly mutated genes such as the tumor suppressor p53. Resequencing of an individual patient's DNA by conventional Sanger methods is impractical, calling for novel methods for sequence analysis. Toward this end, an arrayed primer extension (APEX) method for identifying sequence alterations in primary DNA structure was developed. A two-dimensional array of immobilized primers (DNA chip) was fabricated to scan p53 exon 7 by single bases. Primers were immobilized with 200 microm spacing on a glass support. Oligonucleotide templates of length 72 were used to study individual APEX resequencing reactions. A template-dependent DNA polymerase extension was performed on the chip using fluorescein-labeled dideoxynucleotides (ddNTPs). Labeled primers were evanescently excited and the induced fluorescence was imaged by CCD. The average signal-to-noise ratio (S/N) observed was 30:1. Software was developed to analyze high-density DNA chips for sequence alterations. Deletion, insertion, and substitution mutations were detected. APEX can be used to scan for any mutation (up to two-base insertions) in a known region of DNA by fabricating a DNA chip comprising complementary primers addressing each nucleotide in the wild-type sequence. Since APEX is a parallel method for determining DNA sequence, the time required to assay a region is independent of its length. APEX has a high level of accuracy, is sequence-based, and can be miniaturized to analyze a large DNA region with minimal reagents.
Shumaker
J M
JM
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Tollet
J J
JJ
Filbin
K J
KJ
Montague-Smith
M P
MP
Pirrung
M C
MC
D004252:DNA Mutational Analysis / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D017931:DNA Primers; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics*; D005091:Exons; D019793:Fluorescein; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012984:Software
D017931:DNA Primers; D004273:DNA, Neoplasm; D019793:Fluorescein